Salmedix's Acquisition

Salmedix was acquired by Cephalon on June 17, 2005.

Salmedix was a start-up biotechnology firm focused on discovering and developing minimally-toxic therapies to treat cancers, particularly those that affect the growing global geriatric population.…

Articles about Salmedix's Acquisition: